Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Veradigm ( (MDRX) ) has issued an announcement.
On August 18, 2025, Veradigm announced the appointment of Donald Trigg as the new Chief Executive Officer, effective September 2, 2025. Trigg, who has extensive experience in healthcare technology, previously served as CEO of apree health and held senior roles at Cerner Corporation. His leadership is expected to drive Veradigm’s growth and innovation, leveraging his strategic vision and execution excellence to enhance the company’s industry leadership and deliver value to clients and shareholders.
The most recent analyst rating on (MDRX) stock is a Hold with a $5.00 price target. To see the full list of analyst forecasts on Veradigm stock, see the MDRX Stock Forecast page.
More about Veradigm
Veradigm is a healthcare technology company that provides data-driven solutions and technology to healthcare providers, payers, and the biopharma market. The company focuses on improving clinical quality, reducing administrative burdens, and lowering healthcare costs through its platforms, data, expertise, connectivity, and scale.
Average Trading Volume: 107,073
Technical Sentiment Signal: Sell
Current Market Cap: $780.1M
See more insights into MDRX stock on TipRanks’ Stock Analysis page.